Astellas Pharma Inc 2008 SR
The report outlines Astellas Pharma's CSR activities for fiscal 2007, focusing on its Vision 2015 and the implementation of CSR-based management. Key highlights include the launch of the WIND project to promote diversity and the establishment of medium-term global warming targets for 2020. The company achieved a reduction in global CO2 emissions to 192,000 tons and maintained a low work-related injury severity rate of 0.001. Additionally, the report details environmental performance across global facilities, including energy and water consumption, and highlights social contribution initiatives such as support for organ transplant networks and international NGOs.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2008
Type: SR
Pages: 60
Back to company
Astellas Pharma Inc
CSR Report
The report outlines Astellas Pharma's CSR activities for fiscal 2007, focusing on its Vision 2015 and the implementation of CSR-based management. Key highlights include the launch of the WIND project to promote diversity and the establishment of medium-term global warming targets for 2020. The company achieved a reduction in global CO2 emissions to 192,000 tons and maintained a low work-related injury severity rate of 0.001. Additionally, the report details environmental performance across global facilities, including energy and water consumption, and highlights social contribution initiatives such as support for organ transplant networks and international NGOs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
Apr 1, 2007 - Mar 31, 2008
Fiscal Year
2007
Published
Aug 1, 2008
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees